Yunhui Jo
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Enhanced anti-tumor effects of combined electric fields, cabozantinib, and radiation therapy in metastatic renal cell carcinoma.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: January 22, 2025
Synergistic effects of combined hyperthermia and electric fields treatment in non-small cell lung-cancer (NSCLC) cell lines.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: September 12, 2024
Synergistic effect of TTF and 5-FU combination treatment on pancreatic cancer cells.
Journal: American journal of cancer research
Published: July 16, 2023
Inter-fractional entrance dose monitoring as quality assurance using Gafchromic EBT3 film.
Journal: Journal of cancer research and therapeutics
Published: September 23, 2022
Study of a plastic scintillating plate-based quality assurance system for pencil beam scanning proton beams.
Journal: Journal of cancer research and therapeutics
Published: April 30, 2022
The combination of tumor treating fields and hyperthermia has synergistic therapeutic effects in glioblastoma cells by downregulating STAT3.
Journal: American journal of cancer research
Published: December 10, 2021
Tumor treating fields (TTF) treatment enhances radiation-induced apoptosis in pancreatic cancer cells.
Journal: International journal of radiation biology
Published: October 19, 2020
Sorafenib increases tumor treating fields-induced cell death in glioblastoma by inhibiting STAT3.
Journal: American journal of cancer research
Published: August 06, 2020
Effectiveness of a Fractionated Therapy Scheme in Tumor Treating Fields Therapy.
Journal: Technology in cancer research & treatment
Published: May 11, 2019
Functional Biological Activity of Sorafenib as a Tumor-Treating Field Sensitizer for Glioblastoma Therapy.
Journal: International journal of molecular sciences
Published: October 01, 2018
Last Updated: 09/26/2026